About 80–90% of MG patients have detectable serum antibodies against AChRs with 40–70% of the remaining patients being positive for anti-MuSK antibodies and 2–50% for anti-LRP4 antibodies [12], [16]–[18], [46]. Here, LRP4 is linked to myasthenia gravis.